Innovation, Experience, and Quality

Article

The One Use-Plus SBK, the new generation of LASIK microkeratomes, achieves accuracy and visual results equivalent to femtolasers at a fraction of the cost.

For nearly two centuries, Moria has developed, manufactured, and distributed sophisticated, high quality, innovative ophthalmic surgical instrumentation and equipment that contribute to improved surgical outcomes.

The One Use-Plus SBK, the new generation of LASIK microkeratomes, achieves accuracy and visual results equivalent to femtolasers… at a fraction of the cost. The One Use-Plus SBK produces predictable, thin flaps with planar profiles, resulting in outstanding visual outcomes that are equivalent or better than those attained with a femtolaser. This excellent performance is achieved with less discomfort to the patient, none of the complications associated with the laser, and at a significantly lower cost to the refractive practice.

Working closely with leading corneal surgeons, Moria has been at the forefront of the DSAEK revolution and helped make it the surgical procedure of choice for posterior corneal pathologies. Today Moria, more than ever, is keeping ahead with a promising new technique, Ultra-Thin DSAEK.

The One® range of single-use, high precision, hand-held surgical instruments provide increased safety, convenience, and efficiency in cataract surgery. It’s the guarantee of 100% cleanliness and sterility for each patient and the guarantee of new, precise, undamaged instruments for each procedure.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.